Gamma Investing LLC Recursion Pharmaceuticals, Inc. Transaction History
Gamma Investing LLC
- $734 Billion
- Q2 2024
A detailed history of Gamma Investing LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 6,416 shares of RXRX stock, worth $47,478. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,416
Previous 380
1588.42%
Holding current value
$47,478
Previous $3.79 Million
1169.99%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RXRX
# of Institutions
260Shares Held
193MCall Options Held
787KPut Options Held
1.52M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl24.6MShares$182 Million1.75% of portfolio
-
Baillie Gifford & CO24.1MShares$178 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$119 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.3MShares$91.2 Million0.0% of portfolio
-
Kinnevik Ab (Publ) Stockholm, V711.9MShares$88.1 Million100.0% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.34B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...